javad kiani

[ 1 ] - Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety)

Because of less systemic side effects of topical medications in pain relief of the painful form of diabetic peripheral neuropathy, this study aimed to compare the effect of amitriptyline and capsaicin cream in relieving pain in this condition. In this randomized, double-blind and non -inferiority trial, 102 patients received amitriptyline 2% and capsaicin 0.75% creams 3 times a day for 12 week...

[ 2 ] - Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety)

Because of less systemic side effects of topical medications in pain relief of the painful form of diabetic peripheral neuropathy, this study aimed to compare the effect of amitriptyline and capsaicin cream in relieving pain in this condition. In this randomized, double-blind and non -inferiority trial, 102 patients received amitriptyline 2% and capsaicin 0.75% creams 3 times a day for 12 week...

[ 3 ] - مقایسه سطح سرمی تستسترون در مردان دیابتی با و بدون نوروپاتی محیطی

Introduction & Objective: Diabetic peripheral neuropathy is a common side effect of diabetes mellitus. In addition to known factors such as hyperglycemia, other factors may also be in-volved in the development of this complication. The aim of this study was to evaluate the role of testosterone in diabetic peripheral neuropathy by comparing its level in two groups of diabetic men with and with...

[ 4 ] - Association between serum uric acid level and diabetic peripheral neuropathy (A case control study)

Abstract Background: The role of uric acid is well known for the development of nephropathy and retinopathy in diabetic patients. The aim of this study was to evaluate the serum uric acid levels in patients with or without diabetic neuropathy (DPN). Methods: Forty-two patients with DPN (case group) and 42 patients without DPN (control group) matched with regard to age, gender, body mass index...